MedTrace Logo

Observational Follow-up of Participants From Clinical Trial 64,185-202 (NCT00850993)

NCT02033096 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2019-10-15

No results posted yet for this study

Summary

Observational follow-up of participants from earlier interventional trial 64,185-202 (NCT00850993).

No interventions were administered during this follow-up study.

Conditions

  • Jaundice
  • Neonatal Hyperbilirubinemia

Interventions

DRUG

Stannsoporfin

No intervention was administered during this observational study

DRUG

Placebo Control

No intervention was administered during this observational study

OTHER

Phototherapy (as needed)

No intervention was administered during this observational study

Sponsors & Collaborators

  • InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company

    lead INDUSTRY

Principal Investigators

  • Clinical Study Leader · Mallinckrodt

Eligibility

Min Age
30 Days
Max Age
4 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-20
Primary Completion
2015-06-23
Completion
2015-11-09

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02033096 on ClinicalTrials.gov